Latest Anti-diabetic drug Stories
In a study published last week in the prestigious Proceedings of the National Academy of Sciences of the United States of America, a team led by Dr. Vincent Poitout of the University of Montreal Hospital Research Centre (CRCHUM)* has made an important step forward in understanding how insulin secretion is regulated in the body.
The US Drug Watchdog says, "We totally underestimated the number of diabetics in the United States, who used the diabetes drug called Actos, and now have bladder cancer.
Type 2 diabetes is a common disorder in the United States, with over 8 percent of the general population or more than 20 million people affected by it.
Sucanon is a breakthrough herbal-based treatment of type 2 diabetes, which unlike traditionally used medication is not associated with side effects or harmful metabolic changes in the body.
The US Drug Watchdog says, "We think diabetics using the diabetes drug called Actos, who then developed bladder cancer may become one of our group's more important drug initiatives ever.
The US Drug Watchdog says, "We do not think the average bladder cancer victim, who is also a diabetic would ever consider a drug for diabetes could be a contributing factor for bladder cancer,
Sucanon announces a new diabetes treatment that works in a natural manner by increasing the sensitivity of body tissues to circulating insulin and providing relief of unpleasant diabetes symptoms
Using a blend of technologies, scientists from the Florida campus of The Scripps Research Institute have painted a new picture of how biochemical information can be transmitted through the modification of a protein.
The clinical benefits of Sucanon were convincingly demonstrated in a double-blind, randomized, placebo- & Glibenclamide controlled, multi-center, efficacy and safety study in 370 adult patients
- A volcanic mudflow.